Demand Is Highest Where Clinics Are Few
Iowa's Medicare patients received $86.2M in clinic-administered infusion drugs in 2024, across just 8 registered infusion clinics. That is $10.8M per clinic. Colorado spent $101M but has 87 registered clinics, or $1.2M each.
The gap is a rough signal, not a census: many infusions happen in hospital outpatient departments and oncology practices that never register as an infusion clinic, and Medicare is only part of the market. But the states at the top are where a new independent clinic has the most room, and where patients are most likely to drive far for care.
Medicare Infusion Dollars per Registered Clinic
The six highest and six lowest states with over $50M in payments. Full table below.
Fastest-Growing States
Medicare clinic infusion spending grew fastest from 2022 to 2024 in Wisconsin (+113%), Kansas (+38%), California (+33%), Pennsylvania (+32%), Minnesota (+27%). Growth on a small base can come from a single new drug or practice, so read these alongside the dollar totals.
Every State
Method
Medicare spending: CMS Medicare Physician and Other Practitioners by Provider and Service, for Part B drug codes where at least half of payments go to providers who also bill infusion administration (CPT 96360 to 96379 and 96413 to 96417). Skin substitutes and vaccines are excluded. It covers doctors' and clinics' claims only, not hospital outpatient or home infusion. Clinics: organizations registered in the CMS National Provider Registry under taxonomy 261QI0500X (Clinic/Center, Infusion Therapy), checked November 8, 2026, with duplicate registrations merged and IV hydration lounges excluded.
Need this cut by county, drug or payer for your market? Greyfield Data builds infusion analytics for clinic operators and investors.